Migration to a new platform delivers benefits
Global pharmaceutical company Pfizer has a site at Sandwich in Kent which is its European research and development headquarters, currently employing some 3,500 people. Pfizer’s Sandwich laboratories have an excellent track record of discovering medicines that improve world health and some of Pfizer’s most important medicines, treating diseases such as HIV and cardiovascular disease, were discovered here.
At the Sandwich site there was a need to migrate to a new base platform while retaining the existing application software. This application, which involved Wonderware, focuses on the Kilo Laboratory and the Pilot Plant areas of Pfizer’s Sandwich site. The former produces small (i.e. 1 kilo) quantities of substances for compound development, while the latter produces larger, yet still small, quantities of packaged products for clinical trials.